Literature DB >> 1977298

Introduction--Technetium-99m myocardial perfusion imaging agents and their relation to thallium-201.

D S Berman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1977298     DOI： 10.1016/0002-9149(90)90604-y

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  10 in total

1.  Improved diagnostic accuracy of planar imaging with technetium 99m-labeled tetrofosmin compared with thallium-201 for the detection of coronary artery disease.

Authors:  R S Khattar; R C Hendel; J C Crawley; F J Wackers; P Rigo; B L Zaret; B S Sridhara; A Lahiri
Journal:  J Nucl Cardiol       Date:  1997 Jul-Aug       Impact factor: 5.952

2.  Myocardial ischemia in Kawasaki disease: evaluation with dipyridamole stress technetium 99m tetrofosmin scintigraphy.

Authors:  Tsuyoshi Fukuda; Masatoshi Ishibashi; Tatsuo Yokoyama; Masaki Otaki; Tohru Shinohara; Yoshihide Nakamura; Toshiharu Miyake; Takashi Kudoh; Hidetaka Oku
Journal:  J Nucl Cardiol       Date:  2002 Nov-Dec       Impact factor: 5.952

Review 3.  What is the current status of quantification and nuclear medicine in cardiology?

Authors:  G Hör
Journal:  Eur J Nucl Med       Date:  1996-07

4.  Technetium 99m furifosmin regional myocardial uptake in patients with previous myocardial infarction: relation to thallium-201 activity and left ventricular function.

Authors:  A Cuocolo; G Rubini; W Acampa; E Nicolai; L Florimonte; G DiGiovine; A D'Addabbo; M Salvatore
Journal:  J Nucl Cardiol       Date:  2000 May-Jun       Impact factor: 5.952

5.  Accuracy of 99mTc-tetrofosmin myocardial tomography in the evaluation of coronary artery disease.

Authors:  S Azzarelli; A R Galassi; R Foti; C Mammana; S Musumeci; G Giuffrida; C Tamburino
Journal:  J Nucl Cardiol       Date:  1999 Mar-Apr       Impact factor: 5.952

6.  Comparison of technetium 99m-tetrofosmin and thallium-201 single photon emission computed tomographic imaging for the assessment of viable myocardium in patients with left ventricular dysfunction.

Authors:  A R Galassi; C Tamburino; R Grassi; R Foti; C Mammana; A Virgilio; G Licciardello; S Musumeci; G Giuffrida
Journal:  J Nucl Cardiol       Date:  1998 Jan-Feb       Impact factor: 5.952

7.  Technetium 99m-labeled tetrofosmin myocardial tomography in patients with coronary artery disease: comparison between adenosine and dynamic exercise stress testing.

Authors:  A Cuocolo; E Nicolai; A Soricelli; L Pace; A Nappi; P Sullo; S Cardei; L Argenziano; P J Ell; M Salvatore
Journal:  J Nucl Cardiol       Date:  1996 May-Jun       Impact factor: 5.952

Review 8.  Rationale for the rational development of new cardiac imaging agents.

Authors:  D D Miller
Journal:  Ann Nucl Med       Date:  1993-11       Impact factor: 2.668

9.  Comparison between exercise and trans-oesophageal atrial pacing in patients with coronary artery disease: technetium-99m methoxy isobutyl isonitrile simultaneous evaluation of ventricular function and myocardial perfusion.

Authors:  A Cuocolo; M Santomauro; L Pace; L Celentano; A Nappi; E Nicolai; M Chiariello; M Salvatore
Journal:  Eur J Nucl Med       Date:  1992

10.  Adenosine coronary vasodilation quantitative technetium 99m methoxy isobutyl isonitrile myocardial tomography in the identification and localization of coronary artery disease.

Authors:  E Nicolai; A Cuocolo; L Pace; A Nappi; P Sullo; S Cardei; L Argenziano; F Squame; P J Ell; M Salvatore
Journal:  J Nucl Cardiol       Date:  1996 Jan-Feb       Impact factor: 5.952
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.